Corpus Intelligence IC Memo — PAM SPECIALTY HOSPITAL OF DAYTON 2026-04-26 09:36 UTC
IC Memo — PAM SPECIALTY HOSPITAL OF DAYTON
Investment Committee Memorandum | OH | 44 beds | Grade D | EBITDA uplift $1.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PAM SPECIALTY HOSPITAL OF DAYTON

CCN 362028 | MONTGOMERY, OH | 44 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

PAM SPECIALTY HOSPITAL OF DAYTON is a 44-bed suburban community hospital in MONTGOMERY, OH with $17.0M in net patient revenue and a 2.9% operating margin. The hospital serves a payer mix of 43.7% Medicare, 2.2% Medicaid, and 54.1% commercial.

Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.9% to 10.2% (+736bps).

Net Revenue HCRIS$17.0M
Current EBITDA COMPUTED$487K
Operating Margin COMPUTED2.9%
Occupancy HCRIS55.5%
Revenue / Bed COMPUTED$387K
Net-to-Gross HCRIS17.7%
Distress Probability ML46.7%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
116
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 2.9% places it above the state median. Among 116 size-comparable peers (22-88 beds), the median margin is -1.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-88), prioritizing same-state peers. 116 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PAM SPECIALTY HOSPITAL OF DAYT (Target)OH44$17.0M2.9%
KNOX COMMUNITY HOSPITALOH64$196.0M-16.7%
CRYSTAL CLINIC ORTHOPAEDIC CENOH59$173.3M-14.9%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
OBLENESS MEMORIAL HOSPITALOH67$160.9M29.9%
MEMORIAL HOSPITAL OF UNION COUOH51$151.0M8.0%
FISHER-TITUS MEDICAL CENTEROH78$148.3M-6.9%
WESTERN RESERVE HOSPITALOH83$147.6M-9.3%
GRADY MEMORIAL HOSPITALOH60$146.7M16.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$358K+210bp18mo
Cost to Collect4.5%2.5%$341K+200bp12mo
Denial Rate Reduction12.0%6.5%$337K+198bp12mo
A/R Days Reduction5200.0%3800.0%$207K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$358K
Cost to Collect
$341K
Denial Rate Reduction
$337K
A/R Days Reduction
$207K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.3M
Current EBITDA$487K
+ RCM Uplift+$1.3M
Pro Forma EBITDA$1.7M
Current Margin2.9%
Pro Forma Margin10.2%
WC Released (1x)$653K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$749K$15.7M21.02x83.9%
Base (11x exit)10.0x11.0x$749K$17.6M23.45x87.9%
Bull Case9.0x11.0x$674K$21.9M32.55x100.7%
Bull (12x exit)9.0x12.0x$674K$24.1M35.81x104.6%
Bear Case11.0x10.0x$824K$9.2M11.21x62.2%
Bear (11x exit)11.0x11.0x$824K$10.4M12.66x66.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 116 hospitals with 22-88 beds
  • Same-state prioritization (n=117)
  • Comp margins: P25=-12.7% / P50=-1.7% / P75=10.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.